Similar articles for PMID: 28062403

Year	Number of Results
1962	1
1989	1
2002	1
2004	2
2005	1
2006	6
2007	7
2008	8
2009	5
2010	10
2011	8
2012	12
2013	16
2014	9
2015	9
2016	24
2017	17
2018	15
2019	11
2020	14
2021	9
2022	8
2023	1
2024	0

1

Mutated Chromatin Regulatory Factors as Tumor Drivers in Cancer.

Koschmann C, Nunez FJ, Mendez F, Brosnan-Cashman JA, Meeker AK, Lowenstein PR, Castro MG. Koschmann C, et al. Cancer Res. 2017 Jan 15;77(2):227-233. doi: 10.1158/0008-5472.CAN-16-2301. Epub 2017 Jan 6. Cancer Res. 2017. PMID: 28062403 Free PMC article. Review.

2

Molecular Pathways: Metabolic Control of Histone Methylation and Gene Expression in Cancer.

Tran TQ, Lowman XH, Kong M. Tran TQ, et al. Clin Cancer Res. 2017 Aug 1;23(15):4004-4009. doi: 10.1158/1078-0432.CCR-16-2506. Epub 2017 Apr 12. Clin Cancer Res. 2017. PMID: 28404599 Free PMC article. Review.

3

Altered primary chromatin structures and their implications in cancer development.

Ferraro A. Ferraro A. Cell Oncol (Dordr). 2016 Jun;39(3):195-210. doi: 10.1007/s13402-016-0276-6. Epub 2016 Mar 23. Cell Oncol (Dordr). 2016. PMID: 27007278 Review.

4

Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.

Sigalotti L, Fratta E, Coral S, Cortini E, Covre A, Nicolay HJ, Anzalone L, Pezzani L, Di Giacomo AM, Fonsatti E, Colizzi F, Altomonte M, Calabrò L, Maio M. Sigalotti L, et al. J Cell Physiol. 2007 Aug;212(2):330-44. doi: 10.1002/jcp.21066. J Cell Physiol. 2007. PMID: 17458893 Review.

5

Epigenetics and cancer: altered chromatin remodeling via Snf5 loss leads to aberrant cell cycle regulation.

Sansam CG, Roberts CW. Sansam CG, et al. Cell Cycle. 2006 Mar;5(6):621-4. doi: 10.4161/cc.5.6.2579. Epub 2006 Mar 15. Cell Cycle. 2006. PMID: 16582616 Review.

6

Epigenetic changes in cancer.

Iacobuzio-Donahue CA. Iacobuzio-Donahue CA. Annu Rev Pathol. 2009;4:229-49. doi: 10.1146/annurev.pathol.3.121806.151442. Annu Rev Pathol. 2009. PMID: 18840073 Review.

7

DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.

Herranz M, Esteller M. Herranz M, et al. Methods Mol Biol. 2007;361:25-62. doi: 10.1385/1-59745-208-4:25. Methods Mol Biol. 2007. PMID: 17172706 Review.

8

DNA methylation and chromatin modifiers in colorectal cancer.

Vymetalkova V, Vodicka P, Vodenkova S, Alonso S, Schneider-Stock R. Vymetalkova V, et al. Mol Aspects Med. 2019 Oct;69:73-92. doi: 10.1016/j.mam.2019.04.002. Epub 2019 Apr 30. Mol Aspects Med. 2019. PMID: 31028771 Review.

9

Setting and resetting of epigenetic marks in malignant transformation and development.

Richly H, Lange M, Simboeck E, Di Croce L. Richly H, et al. Bioessays. 2010 Aug;32(8):669-79. doi: 10.1002/bies.201000016. Bioessays. 2010. PMID: 20658705 Review.

10

Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical Implications.

Silverman BR, Shi J. Silverman BR, et al. Int J Mol Sci. 2016 Dec 19;17(12):2138. doi: 10.3390/ijms17122138. Int J Mol Sci. 2016. PMID: 27999365 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

171 results

Results by year